C8H17NO5
207.22 g/mol
APIWarning
Glyset
CAS72432-03-2EC276-661-6
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Miglitol, marketed as Glyset, is an active pharmaceutical ingredient used in oral dosage forms for the management of type 2 diabetes. It functions as an alpha-glucosidase inhibitor, delaying carbohydrate digestion and reducing postprandial glucose levels.
active pharmaceutical ingredient for type 2 diabetes managementalpha-glucosidase inhibitor in oral formulations
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 72432-03-2
Related Compounds
ReferenceSame Category
Aniracetam
CAS72432-10-1
pharmaceutical raw material
ReferenceSame Category
Aminophylline dihydrate
CAS72487-55-9
pharmaceutical raw material
ReferenceSame Category
Pirarubicin
CAS72496-41-4
pharmaceutical raw material
ReferenceSame Category
Felodipine
CAS72509-76-3
pharmaceutical raw material
Safety Reference
Warning
H314Causes severe skin burns and eye damage
H315Causes skin irritation
H319Causes serious eye irritation
H361Suspected of damaging fertility or the unborn child
Identifiers
IUPAC Name
(2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol
InChIKey
IBAQFPQHRJAVAV-ULAWRXDQSA-N
SMILES
C1[C@@H]([C@H]([C@@H]([C@H](N1CCO)CO)O)O)O
Synonyms (23)
- Miglitol (JP18/USAN/INN)
- BAY1099;BAY-m1099
- Bay 1099
- Bay m 1099
- Diastabol
- Glyset
- Glyset (TN)
- MIGLITOL [MART.]
- Miglitol (Glyset)
- Miglitolum
- Miglitolum [Latin]
- Plumarol
- Seibule